XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Warrants
12 Months Ended
Dec. 31, 2023
Warrants and Rights Note Disclosure [Abstract]  
Warrants

Note 13. Warrants

The following table summarizes warrant activity for the years ended December 31, 2023, 2022, and 2021:

 

 

 

Warrants

 

 

Weighted average
exercise price

 

Outstanding at December 31, 2020

 

 

15,541

 

 

$

80.43

 

Issued

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

15,541

 

 

 

80.43

 

Issued

 

 

35,255

 

 

 

31.91

 

Exercised

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

50,796

 

 

 

46.75

 

Issued

 

 

28,424

 

 

 

74.75

 

Exercised

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

79,220

 

 

$

56.80

 

Outstanding Warrants

In connection with the entry into the Third Amendment, Hercules received warrants to purchase an aggregate of 18,724 shares of the Company’s common stock at an exercise price of $55.01 per share, and in connection with the draw down of the tranche 1C advance, Hercules received warrants to purchase 9,700 shares of the Company's common stock at an exercise price of $77.31 per share (collectively, the “2023 warrants”). In connection with the entry into the Second Amendment, Hercules received warrants to purchase an aggregate of 35,255 shares of the Company’s common stock at an exercise price of $31.91 per share (the “2022 warrants”), and in connection with the first advance of the 2020 Term Loan, Hercules received warrants to purchase an aggregate of 15,541 shares of the Company’s common stock at an exercise price of $80.43 per share (the “2020 warrants”).

The 2023 warrants, 2022 warrants and 2020 warrants were priced using the volume weighted average price of the Company’s common stock over the ten-day trading period immediately preceding the initial closing, subject to certain limited adjustments as specified in the warrant. The warrants are exercisable for seven years from the date of issuance. The warrants were classified as a component of stockholders’ equity. The relative fair value of the warrants of approximately $1.6 million for the 2023 warrants, $0.8 million for the 2022 warrants and $0.9 million for the 2020 warrants at the time of issuance, which was determined using the Black-Scholes option-pricing model, was recorded as additional paid-in capital and reduced the carrying value of the debt. The discount on the debt is being amortized to interest expense over the term of the debt utilizing the effective interest rate method.


The initial fair value of warrants outstanding was estimated using the Black‑Scholes option pricing model with the following assumptions:

 

Black-Scholes option valuation assumptions

 

2023
warrants

 

 

2022
warrants

 

 

2020
warrants

 

Risk-free interest rate

 

3.6 - 3.9%

 

 

 

3.1

%

 

 

0.5

%

Dividend yield

 

 

 

 

 

 

 

 

 

Volatility

 

92 - 95%

 

 

 

94

%

 

 

88

%

Weighted average contractual term

 

7 years

 

 

7 years

 

 

7 years